Cotinga Pharmaceuticals Inc.

OTC: COTQF · Healthcare · Biotechnology

Canadian filerHQ Toronto, ONReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 38

v0.1 · 5/100 weight · pillars only

↑ listing tenure, disclosure history · ↓ Altman-Z, market scale

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$2.0M

Employees

—

Market cap

$2.2k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02018

Net income-$2.0M-$2.0M2018

Operating income-$2.0M-$2.0M2018

Total assets$928.0k$928.0k2018

Liabilities$2.7M$2.7M2018

Equity-$1.8M-$1.8M2018

Revenue trend

FY2012 – FY2018 · USD

$30.4k

FY12

FY13

FY14

FY15

FY16

FY17

FY18

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Cotinga Pharmaceuticals Inc. booked $0 in FY2018 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Millennium Sustainable Ventures Corp.——Urologix, Inc.——ForU Holdings, Inc.——Viveve Medical, Inc.——

Key facts

CEORichard T. Ho

SectorHealthcare

IndustryBiotechnology

HeadquartersToronto, ON

ExchangeOTC: COTQF

Employees—

IPO date2009-09-28

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.